Physician profile
Kelli Nissen
NPI 1952093692
$6,060.26
in general payments reported to CMS, 2019-2025
24 companies · $4,705 in 2025
The $4,705 reported for 2025 was more than what 99% of Gerontology (Nurse Practitioner) providers received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $1,355 · 2025: $4,705.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,168 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $2,875 · Travel and Lodging: $17.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,167.76 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $2,875.00 |
| Travel and Lodging | $17.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik Nro, INC. | $3,688.38 | 2024-2025 | Prospera |
| Abbvie INC. | $497.25 | 2024-2025 | |
| Boston Scientific Corporation | $371.49 | 2025 | Intracept |
| Biogen, INC. | $183.99 | 2024-2025 | Vumerity, Tysabri |
| Livanova USA, INC. | $166.24 | 2024-2025 | Vns Therapy Sentiva Model 1000 Generator |
| Sk Life Science, INC. | $144.68 | 2024-2025 | |
| Argenx US, INC. | $126.27 | 2024-2025 | Vyvgart Hytrulo, Vyvgart |
| Ucb, INC. | $110.04 | 2024-2025 | Briviact, Nayzilam |
| Merz North America, INC. | $107.51 | 2024 | |
| Celgene Corporation | $93.71 | 2024-2025 | Zeposia |
| Genentech USA, INC. | $89.17 | 2024-2025 | Ocrevus Zunovo, Ocrevus |
| Pfizer INC. | $78.10 | 2025 | |
| Lundbeck LLC | $71.38 | 2025 | Vyepti |
| Jazz Pharmaceuticals INC. | $65.25 | 2025 | |
| Eisai INC. | $61.10 | 2024-2025 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $33.57 | 2025 | Senza |
| C2n Diagnostics, LLC | $27.46 | 2025 | Precivityad2 |
| Otsuka America Pharmaceutical, INC. | $27.33 | 2025 | Rexulti |
| Spr Therapeutics, INC | $24.06 | 2024 | Sprint Pns System |
| Janssen Biotech, INC. | $20.82 | 2025 | |
| Forte Bio-Pharma LLC | $20.16 | 2024 | Prolate, Nalocet |
| Octapharma USA, INC. | $18.36 | 2024 | Panzyga |
| Lilly USA, LLC | $17.99 | 2025 | Amyvid, Kisunla |
| Novartis Pharmaceuticals Corporation | $15.95 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kelli Nissen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.